Home Sulfos 4-Chlorobenzenesulfonamide

4-Chlorobenzenesulfonamide

CAS No.:
98-64-6
Catalog Number:
AG003L6G
Molecular Formula:
C6H6ClNO2S
Molecular Weight:
191.6353
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
98%
In Stock USA
United States
$13
- +
25g
98%
In Stock USA
United States
$19
- +
100g
98%
In Stock USA
United States
$63
- +
500g
98%
In Stock USA
United States
$188
- +
Product Description
Catalog Number:
AG003L6G
Chemical Name:
4-Chlorobenzenesulfonamide
CAS Number:
98-64-6
Molecular Formula:
C6H6ClNO2S
Molecular Weight:
191.6353
MDL Number:
MFCD00007936
IUPAC Name:
4-chlorobenzenesulfonamide
InChI:
InChI=1S/C6H6ClNO2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,(H2,8,9,10)
InChI Key:
HHHDJHHNEURCNV-UHFFFAOYSA-N
SMILES:
Clc1ccc(cc1)S(=O)(=O)N
EC Number:
202-689-5
Properties
Complexity:
213  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
190.981g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
191.629g/mol
Monoisotopic Mass:
190.981g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
68.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.2  
Literature
Title Journal
4-Chloro-N-(3-methyl-benzo-yl)benzene-sulfonamide monohydrate. Acta crystallographica. Section E, Structure reports online 20120101
N-(4-Chloro-phenyl-sulfon-yl)-2-methyl-propanamide. Acta crystallographica. Section E, Structure reports online 20110901
N,N'-Bis(4-chloro-phenyl-sulfon-yl)suberamide. Acta crystallographica. Section E, Structure reports online 20110801
N,N'-Bis(4-chloro-phenyl-sulfon-yl)-adipamide. Acta crystallographica. Section E, Structure reports online 20110801
Potassium N,4-dichloro-benzene-sulfonamidate monohydrate. Acta crystallographica. Section E, Structure reports online 20110701
Correlation analyses on binding affinity of substituted benzenesulfonamides with carbonic anhydrase using ab initio MO calculations on their complex structures (II). Bioorganic & medicinal chemistry letters 20110101
Identification of N-(2-(azepan-1-yl)-2-phenylethyl)-benzenesulfonamides as novel inhibitors of GlyT1. Bioorganic & medicinal chemistry letters 20100815
4-Chloro-N-(4-methyl-benzo-yl)benzene-sulfonamide. Acta crystallographica. Section E, Structure reports online 20100601
2-Chloro-benzene-sulfonamide. Acta crystallographica. Section E, Structure reports online 20090901
o-Toluene-sulfonamide: a redetermination. Acta crystallographica. Section E, Structure reports online 20090901
2,2-Dichloro-N-(4-chloro-phenyl-sulfon-yl)-acetamide. Acta crystallographica. Section E, Structure reports online 20080801
N-(4-Chloro-phenyl-sulfon-yl)-2,2,2-tri-methyl-acetamide. Acta crystallographica. Section E, Structure reports online 20080701
Novel use of chemical shift in NMR as molecular descriptor: a first report on modeling carbonic anhydrase inhibitory activity and related parameters. Bioorganic & medicinal chemistry letters 20050215
Topological modeling of lipophilicity, diuretic activity, and carbonic inhibition activity of benzene sulfonamides: a molecular connectivity approach. Bioorganic & medicinal chemistry letters 20041115
Synthesis and photoinduced DNA cleaving activity of hairpin polyamide-chlorobenzenesulfonyl conjugates. Photochemistry and photobiology 20030801
Dihydroorotase catalyzes the ring opening of the hydrolysis intermediates of the cardioprotective drug dexrazoxane (ICRF-187). Drug metabolism and disposition: the biological fate of chemicals 20021201
Absorption of a mutagenic metabolite released from protein-bound residues of furazolidone. Environmental toxicology and pharmacology 20020701
Properties